Menta Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Menta Capital’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-82,140	Closed	-$1.23M	–	1075
2016 Q2	$1.23M	Buy	82,140 +20,510	+33%	+$263K	0.17%	176
2016 Q1	$750K	Buy	+61,630	New	+$864K	0.1%	323
2015 Q3	–	Sell	-32,889	Closed	-$800K	–	905
2015 Q2	$800K	Buy	+32,889	New	+$788K	0.13%	303
2014 Q3	–	Sell	-25,197	Closed	-$652K	–	732
2014 Q2	$652K	Buy	25,197 +11,700	+87%	+$260K	0.12%	235
2014 Q1	$315K	Buy	13,497 +4,900	+57%	+$107K	0.09%	263
2013 Q4	$218K	Sell	8,597 -21,883	-72%	-$494K	0.09%	290
2013 Q3	$622K	Sell	30,480 -600	-2%	-$13.4K	0.32%	96
2013 Q2	$652K	Buy	+31,080	New	+$555K	0.42%	57

Menta Capital's SGNT Position: Q3 2016 in Review

Menta Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 82,140 shares — an estimated $1.23M sold.

Menta Capital first reported a position in SGNT in Q2 2013 and held it in 8 quarters. The position peaked at $1.23M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Menta Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Menta Capital sold 82,140 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.23M.
Menta Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
Menta Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.23M in Q2 2016.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Menta Capital's 13F filing for Q3 2016, filed 14 Nov 2016.